Parathyroid Hormone as a Novel Biomarker for Chronic Obstructive Pulmonary Disease: Korean National Health and Nutrition Examination Survey.
Where this comes from
- Record sourced from PubMed, PMID 26398210.
- Also identified by DOI 10.1371/journal.pone.0138482 and PMC identifier 4580427.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
OBJECTIVE: To understand and predict chronic obstructive pulmonary disease (COPD), a biomarker that reflects disease severity is needed. RESEARCH DESIGN AND METHODS: Data from 10269 adults aged over 40 years of age were retrieved from the Korea National Health and Nutrition Examination Survey (KNHANES), and 1302 patients met the criteria for COPD. The association between values of vitamin D and parathyroid hormone (PTH), and COPD severity including lung function and quality of life, were analyzed. RESULTS: In COPD patients, lung function was inversely related to PTH values (P = 0.02 for FVC [% predicted]; P < 0.001 for FEV1 [% predicted]); however, the association of lung function with vitamin D levels was not statistically significant in a multivariable analysis. Value of PTH was independently associated with EQ5D-index (P = 0.04), but vitamin D level showed no significant relationship with EQ5D-index (P = 0.59) or EQ5D-VAS (P = 0.81). CONCLUSIONS: Elevation of PTH, unlike vitamin D, is independently associated with COPD severity, and may be a better biomarker for COPD.
Medical subject headings
- Nutrition Surveys
- Parathyroid Hormone
- Pulmonary Disease, Chronic Obstructive